Cancer
About
Research strength A
Groups
The I-Cube Lab aims to foster collaborations between healthcare professionals and scientists to pursue cancer research.
By studying how bacteria resist to bacteriophage infection, our laboratory seeks to discover and engineer new CRISPR and RNA technologies.
In the Burr laboratory, we aim to uncover the molecular mechanisms by which cancer cells evade surveillance and control by the immune system.
The Dehorter Group aims to determine how interneurons shape neuronal networks activity and contribute to circuits balance in health and disease.
The Eyras Group is working to understand the biology of RNA and cancer using computational methods.
The group investigates the molecular basis of processes coordinated by platelets across vascular biology.
Research group led by Dr Amee George.
This group focus on targeting the ribosome to treat disease including cancer and bone marrow disorders.
Discovering biological physics through optics, computing, materials and fluid dynamics.
The Man Group investigates the role of innate immunity in infectious diseases and cancer.
The Soboleva Group studies mechanisms by which epigenetics controls cell differentiation and how those processes are affected in cancer.
The Wen Group focus on developing computational methods and models for RNA-mediated gene regulatory interactions to elucidate their impact on gene regulation, cellular identity, and the pathogenesis of diseases.
Facilities
The ANU Centre for Therapeutic Discovery (ACTD) is a state-of-the-art high-throughput screening facility for biomarker and therapeutic discovery.
Projects
Articles
At just nine years old, Zara Skepev has raised more than $30,000 to support brain cancer research. This remarkable primary school student has been making and selling earrings, with the funds directed to support female researchers at The John Curtin School of Medical Research (JCSMR).
Nine-year-old Zara Skepev is on a mission to support brain cancer research and empower female scientists.
Dr Teresa Bonello and Dr Rachel Woodhouse from The John Curtin School of Medical Research (JCSMR) have been awarded the highly esteemed Research Grant from Cancer Council ACT for their pioneering work in cancer research.
An immune system protein can be manipulated to help overcome bowel cancer, new ANU research has found.